Q3 2024 Holdings
Filed 2024-11-13 | 21 holdings | $172.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Applied Therapeutics Inc(APLT) | COMM | 03828A101 | $55.8M | 6,567,858 | 32.4% |
| Plains GP Holdings LP-Cl(PAGPEUR) | COMM | 72651A207 | $23.5M | 1,272,360 | 13.7% |
| Phathom Pharmaceuticals I(PHAT) | COMM | 71722W107 | $15.7M | 869,927 | 9.1% |
| Achieve Life Sciences Inc(ACHV) | COMM | 004468500 | $11.6M | 2,453,092 | 6.7% |
| Tscan Therapeutics Inc(TCRX) | COMM | 89854M101 | $10.4M | 2,087,139 | 6.0% |
| Akero Therapeutics Inc(AKRO) | COMM | 00973Y108 | $9.9M | 343,729 | 5.7% |
| Madrigal Pharmaceuticals(MDGL) | COMM | 558868105 | $9.1M | 43,032 | 5.3% |
| Avidity Biosciences Inc(RNA) | COMM | 05370A108 | $8.2M | 178,500 | 4.8% |
| Ardelyx Inc(ARDX) | COMM | 039697107 | $7.4M | 1,070,947 | 4.3% |
| Telesat Corp(TSAT) | COMM | 879512309 | $4.8M | 365,781 | 2.8% |
| Abeona Therapeutics Inc(ABEO) | COMM | 00289Y206 | $3.9M | 624,022 | 2.3% |
| Kymera Therapeutics Inc(KYMR) | COMM | 501575104 | $2.7M | 56,359 | 1.5% |
| Syndax Pharmaceuticals in(SNDX) | COMM | 87164F105 | $2.6M | 133,259 | 1.5% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $2.5M | 130,000 | 1.5% |
| Zevra Therapeutics Inc(ZVRA) | COMM | 488445206 | $1.2M | 179,874 | 0.7% |
| Eiger Biopharmaceuticals(72C) | COMM | 28249U204 | $1.2M | 146,381 | 0.7% |
| Athira Pharma Inc | COMM | 04746L104 | $665.8K | 1,492,792 | 0.4% |
| Compass Pathways LTD(CMPS) | COMM | 20451W101 | $504.0K | 80,000 | 0.3% |
| Verrica Pharmaceuticals I | COMM | 92511W108 | $500.2K | 344,937 | 0.3% |
| Maat Pharma Saca | COMM | F5888J116 | $17.8K | 2,397 | 0.0% |
| Chinook Therapeutics(KDNY) | COMM | 169CVR016 | $9.8K | 79,357 | 0.0% |